Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @ConsiliumHC
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @ConsiliumHC
-
Great to see the
#WorldCancerDay
logo on a city skyscraper just outside Consilium HQ today! #London#Healthcare#Communications#WCD2020
pic.twitter.com/fT3syoXkuS
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Consilium Healthcare proslijedio/la je Tweet
Sequana Medical CEO Ian Crosbie is participating in a Fireside Chat at
#LSXWorld today, moderated by@MedtechTinaTan – come along to hear Ian talk about European Markets and IPOs#sequanamedical#alfapump#transforminglivespic.twitter.com/KciOpwu3a0
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Consilium Healthcare proslijedio/la je Tweet
We've been really busy updating our website - come and take a look and remember to check back regularly for the latest news and updates from
@QuantaDT: https://www.quantadt.com/#Quanta#HomeHD#TransitionalCare#Haemodialysispic.twitter.com/bRiEyI9yQ9
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Consilium Healthcare proslijedio/la je Tweet
Great collaboration with the MHRA which has allowed Achilles Therapeutics to take its investigational clonal neoantigen-based therapy from concept into the clinic in less than three years. Read more here:https://www.gov.uk/government/case-studies/innovation-clonal-neoantigen-specific-tumour-infiltrating-lymphocytes-for-cancer-treatment …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Consilium Healthcare proslijedio/la je Tweet
Antony Newton, VP Business Development, talks about the critical importance of sensitivity and how Inivata’s technology is expanding the reach of
#liquidbiopsy into new clinical and pharmaceutical applications - read the new blog herehttps://www.inivata.com/the-critical-importance-of-sensitivity-and-how-inivatas-technology-is-expanding-the-reach-of-liquid-biopsy-into-new-clinical-and-pharmaceutical-applications/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Congratulations to iTeos on this latest milestone!https://twitter.com/iTeosTx/status/1222826970620317700 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Consilium Healthcare proslijedio/la je Tweet
A huge thank you to Prof Sir John Burn & Elaine Warburton for their leadership over the last 12 years & continued support as Vice Chair and Non Exec Director respectively. (2/2)pic.twitter.com/djA2FWBLQq
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Consilium Healthcare proslijedio/la je Tweet
QuantuMDx leadership changes: Neil Butler is appointed Chair and co-founder Jonathan O’Halloran becomes CEO. https://tinyurl.com/wr6sjwu (1/2).pic.twitter.com/5VgofgoQHm
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Consilium Healthcare proslijedio/la je Tweet
We are pleased to announce that we have been awarded a grant of €15 million from the Walloon region to support the clinical development of our two anti-cancer drug programs – further details here: https://www.iteostherapeutics.com/news/iteos-therapeutics-awarded-eu15-million-non-dilutive-funding-walloon-region …
#walloon#belgianbiotech#immunotherapy#cancerHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Consilium Healthcare proslijedio/la je Tweet
Great to be featured in De Tijd, following this morning’s Walloon region grant announcement. https://www.tijd.be/ondernemen/farma-biotech/biotechbedrijf-iteos-krijgt-15-miljoen-van-waalse-overheid/10203666 …
#walloon#belgianbiotech#immunotherapy#cancerHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Consilium Healthcare proslijedio/la je Tweet
L’Echo takes a closer look at our latest financing news. https://www.lecho.be/entreprises/pharma-biotechnologie/la-wallonie-octroie-15-millions-a-iteos/10203792 …
#walloon#belgianbiotech#immunotherapy#cancerHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Consilium Healthcare proslijedio/la je Tweet
iTeos’ CEO Michel Detheux comments on receiving €15 million from the Walloon region, Belgium. Full details of the grant are here: https://bit.ly/2uP0AcT
#walloon#belgianbiotech#immunotherapy#cancerpic.twitter.com/9s00bzCdOk
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Consilium Healthcare proslijedio/la je Tweet
Today we're pleased to announce positive preclinical data supporting PAS-nomacopan as a potential treatment option for back-of-the-eye diseases
#nomacopan - see the full details here:http://investor.akaritx.com/news-releases/news-release-details/akari-therapeutics-announces-preclinical-ophthalmic-data-showing …Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Consilium Healthcare proslijedio/la je Tweet
@QuantaDT announces it will be presenting at the#AnnualDialysis Conference, between 8-11 Feb, in Kansas City. We're pleased to also announce we have filed a 510(k) submission with the FDA for SC+, with a follow-up study planned to extend use to HHD: https://bit.ly/30L1003 pic.twitter.com/AYS6xd6aIS
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Consilium Healthcare proslijedio/la je Tweet
Summit Announces BARDA Expands Ridinilazole Award by $8.8 Million to Include Additional NDA-Enabling Workhttp://bit.ly/36dHHxu
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Consilium Healthcare proslijedio/la je Tweet
A total of £1.3bn was raised by UK-based #biotech companies in 2019, the third best year ever! The UK continues to chart an ambitious global path, with this report demonstrating that investors have great confidence in our#science
https://bia.me/2O29JG7 pic.twitter.com/6LdQcOvbHt
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Consilium Healthcare proslijedio/la je Tweet
If you're traveling home from
#JPM20 and in need of some reading material, look no further – we've got a wrap up of all the latest business & clinical news in the#celltherapy &#genetherapy sector in our weekly sector newsletter: https://mailchi.mp/alliancerm/arm-sector-newsletter-may-31-2758557?e=0174622439 …pic.twitter.com/2BNOa1JdIE
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Consilium Healthcare proslijedio/la je Tweet
2020 is going to be a busy year for the
#regenmed sector! Don't miss a beat – sign up for ARM's weekly sector newsletter and get the latest news straight to your inbox every Thursday: http://bit.ly/REGENNEWSPrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Consilium Healthcare proslijedio/la je Tweet
Some very useful insights in the
@AMRAlliance Life Science Industry Report released today on efforts by the life science industry to control the rise of#AMR. A number of successes to celebrate, and also an important reminder of the pressing work still to be done.https://twitter.com/AMRAlliance/status/1217722333646983168 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Consilium Healthcare proslijedio/la je Tweet
REPOST: Why do
@OnteraInc &@QuantuMDx think they are stronger together vs#bloodstream#infections? Learn more in January DDNews “Stepping up against#sepsis” http://ddn-news.com/index.php?newsarticle=13917 …#diagnosts#infectiousdiseasepic.twitter.com/0pk1eCnQQ3
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.